|
2012 -- S 2640 SUBSTITUTE A | |
|
======= | |
|
LC02097/SUB A | |
|
======= | |
|
STATE OF RHODE ISLAND | |
|
| |
|
IN GENERAL ASSEMBLY | |
|
| |
|
JANUARY SESSION, A.D. 2012 | |
|
| |
|
____________ | |
|
| |
|
S E N A T E R E S O L U T I O N | |
|
CREATING A SPECIAL LEGISLATIVE COMMISSION | |
|
TO STUDY PUBLIC HEALTH THREATS FROM PHARMACEUTICAL HUMAN WASTE | |
|
CONTAMINATION IN THE WATER SUPPLY | |
|
|
      |
|
|
      |
|
     Introduced By: Senators Tassoni, Doyle, Gallo, and Sosnowski | |
|
     Date Introduced: March 01, 2012 | |
|
     Referred To: Senate Health & Human Services | |
|
1-1 |
     WHEREAS, A 2002 study by the United States Geological Survey conducted across 30 |
|
1-2 |
states found that 80 percent of water streams sampled had measurable concentrations of |
|
1-3 |
prescription and nonprescription drugs, steroids, and reproductive hormones; and |
|
1-4 |
     WHEREAS, Many drugs, particularly cytotoxic agents used in the treatment of cancers |
|
1-5 |
such as chemotherapy, have no safe exposure limit, are carcinogenic, mutanagenic, and |
|
1-6 |
teratogenic, and remain active and dangerous long after leaving the human body through waste; |
|
1-7 |
and |
|
1-8 |
     WHEREAS, In some instances, over 90 percent of a utilized drug fails to be absorbed by |
|
1-9 |
the human body and is excreted through waste into the water supply; and |
|
1-10 |
     WHEREAS, The federal Occupation Safety and Health Administration, the |
|
1-11 |
Environmental Protection Agency, and the Centers for Disease Control and Prevention have each |
|
1-12 |
publically expressed concern with the handling and/or disposal of pharmaceuticals, particularly |
|
1-13 |
cytotoxic agents; and |
|
1-14 |
     WHEREAS, Even with effective collection and treatment systems, medical waste |
|
1-15 |
incinerators are not capable of destroying cytotoxic chemicals and no methods are currently |
|
1-16 |
available to sewer treatment facilities to neutralize such chemicals; and |
|
1-17 |
     WHEREAS, Despite these limitations, effective methods of collecting, reducing, and |
|
1-18 |
neutralizing drugs, and rendering them safe for disposal, exist and should be fully explored and |
|
1-19 |
considered; now, therefore be it |
|
2-20 |
     RESOLVED, That a Special Legislative Commission be and the same hereby is created |
|
2-21 |
consisting of seven (7) members: three (3) of whom shall be members of the Senate, not more |
|
2-22 |
than two (2) of whom shall be from the same political party, to be appointed by the President of |
|
2-23 |
the Senate; one of whom shall be the Director of the Department of Health, or designee; one of |
|
2-24 |
whom shall be the Director of the Department of Environmental Management, or designee; one |
|
2-25 |
of whom shall be the Director of the Department of Human Services, or designee; and one of |
|
2-26 |
whom shall be the Rhode Island Attorney General, or designee. |
|
2-27 |
     In lieu of any appointment of a member of the legislature to a permanent advisory |
|
2-28 |
commission, a legislative study commission, or any commission created by a General Assembly |
|
2-29 |
resolution, the appointing authority may appoint a member of the general public to serve in lieu |
|
2-30 |
of a legislator, provided that the Majority Leader or the Minority Leader of the political party |
|
2-31 |
which is entitled to the appointment, consents to the member of the general public. |
|
2-32 |
     The purpose of said commission shall be to make a comprehensive study and provide |
|
2-33 |
recommendations regarding potential public health threats resulting from pharmaceutical, |
|
2-34 |
medical, and human waste contamination in the public water supply and appropriate collection |
|
2-35 |
methods to prevent such contamination. Said study shall include, but not be limited to: |
|
2-36 |
     (1) A comprehensive review of methods currently used in this state by consumers, health |
|
2-37 |
care providers, and others for disposing of unused pharmaceuticals so that they do not enter the |
|
2-38 |
wastewater system; |
|
2-39 |
      (2) A review of programs and systems developed in other local, state, and national |
|
2-40 |
jurisdictions for disposing of unused pharmaceuticals so that they do not enter the wastewater |
|
2-41 |
system; |
|
2-42 |
     (3) Recommendations regarding the development of public education and outreach |
|
2-43 |
program concerning the proper disposal of unused medications, including but not limited to, the |
|
2-44 |
requirement that all physicians, pharmacists, or other health care professionals licensed in the |
|
2-45 |
state of Rhode Island and authorized to prescribe and/or administer chemotherapy treatment |
|
2-46 |
provide written notice to each patient undergoing such treatment as to the hazards posed to |
|
2-47 |
patients and their families in the residential setting of excreted human waste; |
|
2-48 |
     (4) Recommendations, if necessary, regarding statutory and/or regulatory changes to |
|
2-49 |
current processes concerning pharmaceutical and contamination of our water supply, including |
|
2-50 |
the development of sufficient collection methods whereby patients can safely collect and contain |
|
2-51 |
potentially hazardous excreted bodily wastes for a period of time to be defined by the licensed |
|
2-52 |
prescribing practitioner based on the relevant FDA label(s); and |
|
2-53 |
     (5) The potential costs of and recommendations regarding how to finance, such a |
|
2-54 |
program. |
|
3-1 |
     Forthwith upon passage of this resolution, the members of the commission shall meet at |
|
3-2 |
the call of the President of the Senate. Two co-chairs of the commission shall also be selected by |
|
3-3 |
the Senate President. |
|
3-4 |
     Vacancies in said commission shall be filled in like manner as the original appointment. |
|
3-5 |
     The membership of said commission shall receive no compensation for their services. |
|
3-6 |
     All departments and agencies of the state shall furnish such advice and information, |
|
3-7 |
documentary and otherwise, to said commission and its agents as is deemed necessary or |
|
3-8 |
desirable by the commission to facilitate the purposes of this resolution. |
|
3-9 |
     The Joint Committee on Legislative Services is hereby authorized and directed to provide |
|
3-10 |
suitable quarters for said commission; and be it further |
|
3-11 |
     RESOLVED, That the commission shall report its findings and recommendations to the |
|
3-12 |
Senate no later than March 5, 2013, and said commission shall expire on May 31, 2013. |
|
      | |
|
======= | |
|
LC02097/SUB A | |
|
======== | |
|
EXPLANATION | |
|
BY THE LEGISLATIVE COUNCIL | |
|
OF | |
|
S E N A T E R E S O L U T I O N | |
|
CREATING A SPECIAL LEGISLATIVE COMMISSION | |
|
TO STUDY PUBLIC HEALTH THREATS FROM PHARMACEUTICAL HUMAN WASTE | |
|
CONTAMINATION IN THE WATER SUPPLY | |
|
*** | |
|
4-1 |
     This resolution would create a seven (7) member special legislative study commission |
|
4-2 |
whose purpose it would be to study public health threats from pharmaceutical human waste |
|
4-3 |
contamination in the water supply, and who would report back to the Senate no later than March |
|
4-4 |
5, 2013, and whose life would expire on May 31, 2013. |
|
      | |
|
======= | |
|
LC02097/SUB A | |
|
======= |